Stada in ‘exploratory talks’ about possible sale, CEO says, but nothing is certain fkansteiner Tue, 08/15/2023 – 14:18 More: Stada in 'exploratory talks' about possible sale, CEO says, but nothing is certain Source: fierce
read moreSandoz says its biosimilar matches Eylea in another threat to Regeneron’s blockbuster aliu Tue, 08/15/2023 – 11:05 More: Sandoz says its biosimilar matches Eylea in another threat to Regeneron's blockbuster Source: fierce
read moreAs COVID-19 vaccine makers gear up to launch updated shots in the private market, can the new vaccines keep up with the virus? zbecker Tue, 08/15/2023 – 09:48 More: As COVID-19 vaccine makers gear up to launch updated shots in
read moreHow Biogen outbid a rival ‘large-cap’ pharma to claim Reata for $7.3B fkansteiner Tue, 08/15/2023 – 09:40 More: How Biogen outbid a rival 'large-cap' pharma to claim Reata for .3B Source: fierce
read morePersistence pays for Delcath as cancer treatment Hepzato Kit finally scores FDA nod esagonowsky Tue, 08/15/2023 – 09:05 More: Persistence pays for Delcath as cancer treatment Hepzato Kit finally scores FDA nod Source: fierce
read moreThe study concerns the use of Nefecon among adult patients with primary IgA nephropathy More: Calliditas reveals results from vital NefIgArd study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals